Corporate Whistleblower Center Urges Drug or Medical Device Insiders to Call Them If they Have Proof of Fraudulent Speaker Fees Used as Kickbacks

Share Article

The Corporate Whistleblower Center is urging medical device representatives, pharmaceutical sales representatives, or medical doctors to contact them at 866-714-6466 if they possess significant proof of a drug maker or medical device manufacturer bribing physicians with “speaking fees.” These illegal kickbacks are in violation of the False Claims Act and Anti-Kickback Statute, and whistleblowers are rewarded substantial amounts of money for their information. http://CorporateWhistleblowerCenter.Com

News Image
Speaking fees are just another way to induce doctors to prescribe more drugs or to use more of a company’s medical devices

The Corporate Whistleblower Center says, "Speaking fees are just another way to induce doctors to prescribe more drugs or to use more of a company’s medical devices.This type of kickback is in violation of the Anti-Kickback Statute, which prohibits companies from offering payments to induce referrals of items covered by federally-funded programs, and it is bad medicine.”

A recent example of this occurred in July of 2013. According to the Department of Justice, medical device manufacturer Trans1 agreed to pay $6 million to settle claims that it allegedly violated the False Claims Act and Anti-Kickback Statute. According to the lawsuit, among other claims, allegedly Trans1 knowingly paid physicians illegal speaker fees to promote the use of Trans1 products in programs and meetings.

The suit was brought by a whistleblower who will receive just over $1 million for bringing this wrongdoing to light.

The Corporate Whistleblower Center says“If a medical device, drug rep, or doctor can prove these types of kickbacks are happening, we definitely want to talk to them, and we want them to call us at 866-714-6466. We will help them determine whether or not they have sufficient proof to move forward, package their information, and put them in contact with the best whistleblower attorneys in the country. All information will be kept confidential.”

Simple rules for a whistleblower from the Corporate Whistleblower Center:

  • Do not go to the government first if you are a major whistleblower. The Corporate Whistleblower Center says, “Major whistleblowers frequently go to the federal government thinking they will help. It’s a huge mistake.”
  • Do not go to the news media with your whistleblower information. Public revelation of a whistleblower’s information could destroy any prospect for a reward.
  • Do not try to force a government contractor, or corporation to come clean to the government about their wrongdoing. The Corporate Whistleblower Center says, “Fraud is so rampant among federal contractors that any suggestion of exposure might result in an instant job termination, or harassment of the whistleblower. Come to us first, tell us what type of information you have, and if we think it’s sufficient, we will help find the right law firms to assist in advancing your information.”
  • The Corporate Whistleblower Center wants to emphasize there are high quality whistleblowers in every state including California, New York, Florida, Texas, Massachusetts, Maryland, Virginia, Ohio, Pennsylvania, West Virginia, Tennessee, North Carolina, Georgia, Alabama, Louisiana, Missouri, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, Washington, and Alaska.

Any type of insider or employee who possesses significant proof of their employer or a government contractor defrauding the federal government is encouraged to contact to Corporate Whistleblower Center anytime at 866-714-6466 or via their web site at http://CorporateWhistleBlowerCenter.Com

For attribution purposes please refer to the July 3rd 2013 press release from the United States Department of Justice:
Federal Case Number: The civil lawsuit was filed in the District of Maryland and is captioned United States ex rel. Kevin Ryan v. TranS1, Inc-42 U.S.C. § 1320a-7b(b),

Share article on social media or email:

View article via:

Pdf Print

Contact Author

M Thomas Martin
Visit website